Status:
COMPLETED
Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
Lead Sponsor:
Laurence Gabriel
Conditions:
Left Ventricular Hypertrophy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry pat...
Eligibility Criteria
Inclusion
- unexplained left ventricular hypertrophy
Exclusion
- isolated septal hypertrophy
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02221141
Start Date
December 1 2013
End Date
April 1 2021
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Dinant-Godinne
Yvoir, Belgium, 5530